Translating Diabetes

Over recent decades, the incidence of metabolic diseases such as obesity and diabetes has risen to epidemic proportions. Projections into the future suggest increasingly unmet patient needs and an unsustainable challenge for health care systems. Simultaneously, the drug discovery process is facing its own challenges. The number of pharmaceutical companies who are able to conduct expensive late stage clinical trials is declining. Funding for academic laboratories and biotechnology operations is limited. Novel strategies and new insights are needed to treat these diseases.

The 2014 EMBO | EMBL Symposium will focus on "translation" from bench to bedside and from model organism to the clinic.
+ show speakers and program

Keynote Speakers

Domenico Accili
Columbia University, USA

Stephen O'Rahilly
University of Cambridge Metabolic Research Laboratories - Institute of Metabolic Science, UK

Celeste Simon
University of Pennsylvania, USA

Confirmed Speakers

Carolyn Cummins
University of Toronto, Canada

Patrick Collombat
Institut de Biologie de Valrose, France

Hans-Ulrich Häring
University of Tübingen, Germany

Peter Havel
University of California, Davis, USA

Klaus Kaestner
University of Pennsylvania School of Medicine, USA

Anastasia Kralli
The Scripps Research Institute, USA

Heiko Lickert
Helmholtz Zentrum München, Institute of Stem Cell Research, Germany

Hernan Lopez-Schier
Helmholtz Zentrum München, Germany

Kathrin Maedler
University of Bremen, Germany

Adriana Maggi
The University of Milan, Italy

John Reynolds
Trinity College Dublin, Ireland

Michael Ristow
ETH Zürich, Switzerland

Varda Rotter
Weizmann Institute of Science, Israel

Jon Shah
Forschungszentrum Jülich, Germany

Dana Small
The John B. Pierce Laboratory, USA

Steven Smith
Translational Research Institute for Metabolism and Diabetes, Sanford-Burnham Medical Research Institute, USA

Scott Sternson
Janelia Farm, USA

Markus Stoffel
ETH Zurich, Switzerland

Lori Sussel
Columbia University, USA

Kirsi A. Virtanen
Turku PET Centre, University of Turku and Turku University Hospital, Finland

Matthias von Herrath
La Jolla Institute for Allergy & Immunology, USA

Christopher Wright
Vanderbilt University, USA

Thomas Wunderlich
University of Cologne, CECAD - Cluster of Excellence, Germany

Lori Zeltser
The Naomi Berrie, Columbia University, USA

Anette-Gabriele Ziegler
Helmholtz Zentrum München, Germany

30 Apr - 3 May 2014
meeting website